Press release
Diabetics Drugs Market to Reach US$58.4 Bn Valuation by 2025 Due to Rising Instances of Type 2 Diabetes
Rising urbanization, increasing intake of sugary foods, and changing lifestyle preferences like lack of exercise are leading to growth in obesity globally. Earlier, developed markets in US and Europe faced a strong demand for diabetes drugs due to the large number of patients.However, today these patterns are a common sight in developing economies of Asia as well. For example, India has become home to one of the largest diabetic population in the world. This population counted in millions, forms over 8% of India’s total population.
Obtain Report Details @ https://www.transparencymarketresearch.com/diabetes-drug-market.html
FDA Approval to Boost the Diabetes Drugs Market
FDA or the US Food and Drug Administration approved a non-insulin drug for pediatric patients in 2019.
The drug, Victoza has shown efficacy in treating type 2 Diabetes. The drug is behind metformin, which was the first drug to be approved for pediatric patients in 2000.
Victoza has been under the trial since 2010. According to a statement released by FDA, increasing number of children is being diagnosed with the type 2 Diabetes. This prompted the FDA to expand an additional treatment option.
According to Center for Disease Control and Prevention, there are additional 5000 deaths in the US each year among the young population.
Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14672
Technological Advancement Promise New Opportunities
Currently, the pace of technological innovation is leading to growth in many sectors. The medical sector, consisting of pharmaceutical companies and insurance companies are major beneficiaries of this development.
On one hand, technologies like 3D printing, growing sources of outsourcing are leading to major reductions in costs. Additionally, growing support for innovation in major economies like US and China are spelling a boon for the industry.
Moreover, portable monitoring technologies available through smartphones are making way for better healthcare systems and leading to more preventive care for the industry.
This has led to an increase in number of diagnosis. On the other hand, it has helped the insurance support a more solid preventive care framework for the treatment of various diabetics.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetics Drugs Market to Reach US$58.4 Bn Valuation by 2025 Due to Rising Instances of Type 2 Diabetes here
News-ID: 1857209 • Views: …
More Releases from Transparency Market Research
Automated Nucleic Acid Extraction Market Forecast to Reach USD 11.7 Billion by 2 …
The global Automated Nucleic Acid Extraction Market is poised for substantial growth through 2036, driven by the increasing adoption of molecular diagnostics, rising prevalence of infectious and genetic diseases, and the growing integration of automation in clinical laboratories. As healthcare systems worldwide emphasize rapid, high-throughput, and contamination-free diagnostic workflows, automated nucleic acid extraction systems are emerging as essential tools in modern laboratories.
The global Automated Nucleic Acid Extraction Market was valued…
Non-Small Cell Lung Cancer Therapeutics Market to Reach USD 75.5 Billion by 2036 …
The Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market is experiencing remarkable growth due to the increasing prevalence of lung cancer, growing adoption of precision medicine, and rapid advancements in targeted therapies and immunotherapies. NSCLC accounts for nearly 85% of all lung cancer cases, making it the most common type of lung cancer worldwide. Continuous innovations in molecular diagnostics, biomarker testing, and personalized treatment approaches have significantly improved survival rates and…
Organic Soy Protein Market to Reach US$ 1.77 Billion by 2036, Driven by Rising D …
The global organic soy protein market is witnessing strong growth as consumers increasingly seek clean-label, plant-based, and nutritionally balanced food ingredients. Organic soy protein is extracted from organically cultivated soybeans without the use of synthetic pesticides, chemical fertilizers, or genetically modified organisms (GMOs). It serves as a complete plant protein containing all essential amino acids, making it a preferred ingredient across food, beverage, dietary supplements, and specialized nutrition products.
👉 Get…
Autonomous Vehicle Market to Reach US$ 2,208.2 Billion by 2036, Driven by AI Adv …
The global autonomous vehicle market is witnessing remarkable growth as advancements in artificial intelligence (AI), machine learning, sensor technologies, and connected mobility continue to transform the automotive industry. Autonomous vehicles are designed to operate with minimal or no human intervention by leveraging advanced software, cameras, radar, LiDAR, and high-performance computing systems. These vehicles improve road safety, reduce traffic congestion, and enhance transportation efficiency across passenger and commercial mobility applications.
👉 Get…
More Releases for FDA
FDA vs Non-FDA Freeze-Dried Fruit Suppliers: Risk and Market Access Differences
FDA Freeze-Dried Fruit Suppliers vs Non-FDA Approved Producers: Risk and Market Access Differences
Fujian Lixing Food Co., Ltd. - an internationally acclaimed provider of FDA freeze dried fruits and a pioneer in vacuum sublimation technology - today provided an insightful analysis that illuminated critical differences between FDA-registered suppliers and non-approved producers; with rising consumer demand for "clean label" healthy snacks a must, this study illustrates why regulatory compliance must be adhered…
DreaMed receives 5th FDA Clearance
TEL AVIV, Israel: DreaMed Diabetes LTD. ("DreaMed" or the "Company"), developer of the endo.digital Clinical Decision Support System announced today that it has received its 5th U.S Food and Drug Administration (FDA) clearance that expands the scope of AI enhanced treatment recommendations to patients on fixed meal insulin regimens. endo.digital is the first decision support system that has been cleared to assist healthcare providers in the management of diabetes…
FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming
CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility…
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30).
Announcing New Design Control Training Courses
Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a…
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation.
GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet…
FDA online training
Description:
Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding…
